BackZentalis Pharmaceuticals Overview
Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Discounted Cash Flow

DCF Analysis for ZNTL.

Get informed when a big investor buys or sells

+ Follow

Fair Value

$-0.05

Current Fair Value

$-0.05
101.3% Downside

Overvalued by 101.3% based on the discounted cash flow analysis.

Average Upside/Downside (Comparison Companies)

Loading

Fair Value vs. Stock Price History

Loading

Upside/Downside History

Loading

Upside/Downside Comparison

Loading